エピジェネティクスの世界市場:修飾酵素、DNAポリメラーゼ、アセチラーゼ、メチルトランスフェラーゼ、機器、消耗品、キット、試薬

◆英語タイトル:Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020
◆商品コード:MAM-BT-2775
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2016年2月1日
◆ページ数:167
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥581,950見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥684,950見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥839,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、エピジェネティクスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、研究分野別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020. Increasing research activities by academic and research institutes and high prevalence of cancer will majorly drive the growth of the market. Other growth factors include the increasing application for non-oncology diseases; and growing partnership between academic, biotechnology and pharmaceutical companies. The new emerging markets such as Brazil, Russia, India and China will provide opportunities for market growth.

This report segments the global epigenetics market by product and research areas. The global market product segments include enzymes, instruments & consumables, kits and reagents. Enzymes are further subsegmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Instruments & consumables are further subsegmented into mass spectrometers, next-generation sequencers, qPCRs, sonicators and other epigenetics instruments & consumables. Kits are further subsegmented into bisulfite conversion kits, ChIP-seq kits, RNA sequencing kits, whole genomic sequencing kits, 5-hmc and 5-mc analysis kits and other epigenetics kits. Reagents are further subsegmented into antibodies, buffers, histones, magnetic beads, primers and other epigenetics reagents. In 2015, the kits segment is expected to account for the largest share of the global market.

The research area segments of this market are developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases. In 2015, oncology segment is expected to account for the largest share of the global market in epigenetics, whereas, drug discovery is expected to grow at a higher rate during the forecast period.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into the U.S. and Canada. In 2015, the North America is expected to command the largest share of the global epigenetics market. Asia is expected to register the highest growth due to high prevalence of cancer, increasing research activities by various research institutes and increasing R & D funding by biotechnology and pharmaceutical companies in this region.

Major players in the global epigenetics market are Abcam plc. (U.K), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherland), Merck & Co. (U.S.), New England Biolabs, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Active Motif (U.S.), Diagenode, Inc. (Belgium) and Zymo Research Corporation (U.S.).

【レポートの目次】

1 Introduction (Page No. – 11)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope of Epigenetics
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 13)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 20)

4 Premium Insights (Page No. – 23)
4.1 Global Epigenetics Market Overview
4.2 Life Cycle Analysis for Epigenetics, By Region

5 Market Overview (Page No. – 26)
5.1 Introduction
5.2 Market Segmentation of Epigenetics
5.2.1 Epigenetics Market Segmentation: By Product
5.2.2 Epigenetics Market Segmentation: By Research Area
5.3 Market Dynamics of Epigenetics
5.3.1 Drivers
5.3.1.1 High Prevalence of Cancer
5.3.1.2 Growing Funding for Epigenetics-Based Research
5.3.1.3 Increasing Intensity of Research Activities in the Field of Epigenetics
5.3.1.4 Growing Application of Epigenetics in Non-Oncology Diseases
5.3.1.5 Growth in the Number of Partnerships Between Academic Institutes and Biotechnology & Pharmaceutical Companies for Epigenetic-Based Products
5.3.2 Restraints
5.3.2.1 High Cost of Instruments
5.3.2.2 Lack of Trained Professionals
5.3.3 Opportunities
5.3.3.1 Emerging Markets to Present Significant Growth Opportunities

6 Epigenetics Market, By Product (Page No. – 32)
6.1 Introduction
6.2 Enzymes
6.2.1 DNA-Modifying Enzymes
6.2.2 Protein-Modifying Enzymes
6.2.3 Rna-Modifying Enzymes
6.3 Instruments and Consumables
6.3.1 Mass Spectrometers
6.3.2 Next-Generation Sequencers
6.3.3 QPCR
6.3.4 Sonicators
6.3.5 Other Epigenetics Instruments and Consumables
6.4 KITS
6.4.1 Bisulfite Conversion KITS
6.4.2 Chip-Seq KITS
6.4.3 Rna Sequencing KITS
6.4.4 Whole-Genome Amplification KITS
6.4.5 5-HMC and 5-MC Analysis KITS
6.4.6 Other Epigenetics KITS
6.5 Reagents
6.5.1 Antibodies
6.5.2 Buffers
6.5.3 Histones
6.5.4 Magnetic Beads
6.5.5 Primers
6.5.6 Other Epigenetics Reagents

7 Epigenetics Market, By Research Area (Page No. – 60)
7.1 Introduction
7.2 Developmental Biology
7.3 Drug Discovery
7.4 Oncology
7.5 Other Research Areas

8 Epigenetics Market, By Region (Page No. – 69)
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.4 Asia
8.5 Rest of the World (ROW)

9 Competitive Landscape (Page No. – 104)
9.1 Introduction
9.2 Strategic Overview
9.3 Leading Players in the Epigenetics Market
9.4 Competitive Situation and Trends of Epigenetics
9.4.1 New Product and Service Launches
9.4.2 Agreements, Alliances, Collaborations, and Partnerships
9.4.3 Acquisitions
9.4.4 Expansions
9.4.5 Other Developments

10 Company Profiles (Page No. – 114)
10.1 Introduction
10.2 Abcam PLC
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Recent Developments
10.2.4 MnM View
10.2.4.1 Financial Analysis
10.2.4.2 Strategic Analysis
10.3 Active Motif
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Recent Developments
10.3.4 MnM View
10.3.4.1 Strategic Analysis
10.4 Diagenode, Inc.
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Recent Developments
10.4.4 MnM View
10.4.4.1 Strategic Analysis
10.5 Illumina, Inc.
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Recent Developments
10.5.4 MnM View
10.5.4.1 Financial Analysis
10.5.4.2 Strategic Analysis
10.6 Merck & Co., Inc.
10.6.1 Business Overview
10.6.2 Products Offered
10.6.3 Recent Developments
10.6.4 MnM View
10.6.4.1 Financial Analysis
10.6.4.2 Strategic Analysis
10.7 New England Biolabs
10.7.1 Business Overview
10.7.2 Products Offered
10.7.3 Recent Developments
10.7.4 MnM View
10.7.4.1 Strategic Analysis
10.8 Qiagen N.V.
10.8.1 Business Overview
10.8.2 Products Offered
10.8.3 Recent Developments
10.8.4 MnM View
10.8.4.1 Financial Analysis
10.8.4.2 Strategic Analysis
10.9 Sigma-Aldrich Corporation
10.9.1 Business Overview
10.9.2 Products Offered
10.9.3 Recent Developments
10.9.4 MnM View
10.9.4.1 Financial Analysis
10.9.4.2 Strategic Analysis
10.10 Thermo Fisher Scientific, Inc.
10.10.1 Business Overview
10.10.2 Products Offered
10.10.3 Recent Developments
10.10.4 MnM View
10.10.4.1 Financial Analysis
10.10.4.2 Strategic Analysis
10.11 Zymo Research Corporation
10.11.1 Business Overview
10.11.2 Products Offered
10.11.3 Recent Developments
10.11.4 MnM View
10.11.4.1 Strategic Analysis

11 Appendix (Page No. – 148)
11.1 Insights of Industry Experts
11.2 Discussion Guide
11.3 Other Developments in Epigenetics
11.4 Introducing RT: Real-Time Market Intelligence
11.5 Available Customizations
11.6 Related Reports

List of Tables (84 Tables)

Table 1 Epigenetics Market Snapshot
Table 2 High Prevalence of Cancer is A Major Factor Driving Market Growth for Epigenetics
Table 3 High Cost of Instruments to Restrain Market Growth
Table 4 Emerging Economies Expected to Offer Growth Opportunities in the Coming Years
Table 5 Epigenetics Market Size, By Product, 2012–2020 (USD Million)
Table 6 Epigenetics Enzymes Market Size, By Type, 2012–2020 (USD Million)
Table 7 Epigenetics Enzymes Market Size, By Region, 2012–2020 (USD Million)
Table 8 Epigenetics Market Size for DNA-Modifying Enzymes, By Type, 2012–2020 (USD Million)
Table 9 Epigenetics Market Size for DNA-Modifying Enzymes, By Region, 2012–2020 (USD Million)
Table 10 Epigenetics Market Size for Protein-Modifying Enzymes, By Type, 2012–2020 (USD Million)
Table 11 Epigenetics Market Size for Protein-Modifying Enzymes, By Region, 2012–2020 (USD Million)
Table 12 Epigenetics Market Size for Rna-Modifying Enzymes, By Type, 2012–2020 (USD Million)
Table 13 Epigenetics Market Size for Rna-Modifying Enzymes, By Region, 2012–2020 (USD Million)
Table 14 Epigenetics Instruments and Consumables Market Size, By Type, 2012–2020 (USD Million)
Table 15 Epigenetics Instruments and Consumables Market Size, By Region, 2012–2020 (USD Million)
Table 16 Epigenetics Market Size for Mass Spectrometers, By Region, 2012–2020 (USD Million)
Table 17 Epigenetics Market Size for Next-Generation Sequencers, By Region, 2012–2020 (USD Million)
Table 18 Epigenetics Market Size for QPCR, By Region, 2012–2020 (USD Million)
Table 19 Epigenetics Market Size for Sonicators, By Region, 2012–2020 (USD Million)
Table 20 Epigenetics Market Size for Other Instruments and Consumables, By Region, 2012–2020 (USD Million)
Table 21 Epigenetics KITS Market Size, By Type, 2012–2020 (USD Million)
Table 22 Epigenetics KITS Market Size, By Region, 2012–2020 (USD Million)
Table 23 Epigenetics Market Size for Bisulfite Conversion KITS, By Region, 2012–2020 (USD Million)
Table 24 Epigenetics Market Size for Chip-Seq KITS, By Region, 2012–2020 (USD Million)
Table 25 Epigenetics Market Size for Rna Sequencing KITS, By Region, 2012–2020 (USD Million)
Table 26 Epigenetics Market Size for Whole-Genome Amplification KITS, By Region, 2012–2020 (USD Million)
Table 27 Epigenetics Market Size for 5-HMC and 5-MC Analysis KITS, By Region, 2012–2020 (USD Million)
Table 28 Other Epigenetics KITS Market Size, By Region, 2012–2020 (USD Million)
Table 29 Epigenetics Reagents Market Size, By Type, 2012–2020 (USD Million)
Table 30 Epigenetics Reagents Market Size, By Region, 2012–2020 (USD Million)
Table 31 Epigenetics Market Size for Antibodies, By Region, 2012–2020 (USD Million)
Table 32 Epigenetics Market Size for Buffers, By Region, 2012–2020 (USD Million)
Table 33 Epigenetics Market Size for Histones, By Region, 2012–2020 (USD Million)
Table 34 Epigenetics Market Size for Magnetic Beads, By Region, 2012–2020 (USD Million)
Table 35 Epigenetics Market Size for Primers, By Region, 2012–2020 (USD Million)
Table 36 Other Epigenetics Reagents Market Size, By Region, 2012–2020 (USD Million)
Table 37 Epigenetics Market Size, By Research Area, 2012–2020 (USD Million)
Table 38 Epigenetics Market Size for Developmental Biology, By Region, 2012–2020 (USD Million)
Table 39 Epigenetics Market Size for Drug Discovery, By Region, 2012–2020 (USD Million)
Table 40 Epigenetics Market Size for Oncology, By Region, 2012–2020 (USD Million)
Table 41 Epigenetics Market Size for Other Research Areas, By Region, 2012–2020 (USD Million)
Table 42 Epigenetics Market Size, By Region, 2012–2020 (USD Million)
Table 43 North America: Epigenetics Market Size, By Country, 2012–2020 (USD Million)
Table 44 North America: Market Size, By Product, 2012–2020 (USD Million)
Table 45 North America: Epigenetics Enzyme Market Size, By Type, 2012–2020 (USD Million)
Table 46 North America: Market Size, By Instrument and Consumable, 2012–2020 (USD Million)
Table 47 North America: Market Size, By Research Area, 2012–2020 (USD Million)
Table 48 U.S.: Epigenetics Market Size, By Product, 2012–2020 (USD Million)
Table 49 U.S.: Market Size, By Enzyme, 2012–2020 (USD Million)
Table 50 U.S.: Market Size, By Instrument and Consumable, 2012–2020 (USD Million)
Table 51 U.S.: Market Size, By Research Area, 2012–2020 (USD Million)
Table 52 Canada: Epigenetics Market Size, By Product, 2012–2020 (USD Million)
Table 53 Canada: Market Size, By Enzyme, 2012–2020 (USD Million)
Table 54 Canada: Market Size, By Instrument and Consumable, 2012–2020 (USD Million)
Table 55 Canada: Market Size, By Research Area, 2012–2020 (USD Million)
Table 56 Europe: Epigenetics Market Size, By Product, 2012–2020 (USD Million)
Table 57 Europe: Market Size, By Enzyme, 2012–2020 (USD Million)
Table 58 Europe: Market Size, By Instrument and Consumable, 2012–2020 (USD Million)
Table 59 Europe: Epigenetics Market Size, By Research Area, 2012–2020 (USD Million)
Table 60 Asia: Epigenetics Market Size, By Product, 2012–2020 (USD Million)
Table 61 Asia: Market Size, By Enzyme, 2012–2020 (USD Million)
Table 62 Asia: Market Size, By Instrument and Consumable, 2012–2020 (USD Million)
Table 63 Asia: Epigenetics Market Size, By Research Area, 2012–2020 (USD Million)
Table 64 ROW: Market Size, By Product, 2012–2020 (USD Million)
Table 65 ROW: Epigenetics Market Size, By Enzyme, 2012–2020 (USD Million)
Table 66 ROW: Market Size, By Instrument and Consumable, 2012–2020 (USD Million)
Table 67 ROW: Market Size, By Research Area, 2012–2020 (USD Million)
Table 68 Rank of Companies in the Global Market for Epigenetics , 2015
Table 69 Market Developments in Epigenetics, 2011–2015
Table 70 New Product and Service Launches, 2011–2015
Table 71 Agreements, Alliances, Collaborations, and Partnerships , 2011–2015
Table 72 Acquisitions, 2011–2015
Table 73 Expansions, 2011–2015
Table 74 Other Developments in Epigenetics, 2011–2015
Table 75 List of Developments for Abcam PLC, 2011-2015
Table 76 List of Developments for Active Motif, 2011-2015
Table 77 List of Developments for Diagenode, Inc., 2011-2015
Table 78 List of Developments for Illumina, Inc., 2011-2015
Table 79 List of Developments for Merck & Co., Inc., 2011-2015
Table 80 List of Developments for New England Biolabs, 2011-2015
Table 81 List of Developments for Qiagen N.V., 2011-2015
Table 82 List of Developments for Sigma-Aldrich Corporation, 2011-2015
Table 83 List of Developments for Thermo Fisher Scientific, Inc., 2011-2015
Table 84 List of Developments for Zymo Research Corporation, 2011-2015

List of Figures (82 Figures)

Figure 1 Epigenetics Market
Figure 2 Research Design in Epigenetics
Figure 3 Market Size Estimation Methodology in Epigenetics: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology in Epigenetics: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology of Epigenetics
Figure 7 Epigenetics Market Size, By Product, 2015 vs. 2020 (USD Million)
Figure 8 Market Size of Epigenetics, By Research Area of Epigenetics, 2015 vs. 2020 (USD Million)
Figure 9 Market Size of Epigenetics, By Region of Epigenetics, 2015 vs. 2020 (USD Million)
Figure 10 High Prevalence of Cancer to Drive Market Growth of Epigenetics
Figure 11 Oncology Segment to Account for the Largest Market Share in 2015
Figure 12 Asia to Grow At the Highest Rate in the Forecast Period (2015–2020)
Figure 13 Asia Holds Lucrative Growth Opportunities in Epigenetics
Figure 14 Market of Epigenetics: By Product
Figure 15 Epigenetics Market: By Research Area
Figure 16 Market of Epigenetics: Drivers, Restraints, & Opportunities
Figure 17 Epigenetics Market Segmentation, By Product
Figure 18 KITS to Command the Largest Share of the Epigenetics Market in 2015
Figure 19 Epigenetics Enzymes Market Segmentation, By Type
Figure 20 DNA-Modifying Enzymes to Dominate the Epigenetics Enzymes Market in 2015
Figure 21 North America to Form the Largest Regional Segment of the Epigenetics Enzymes Market
Figure 22 DNA-Modifying Enzymes Market Segmentation, By Type
Figure 23 Protein-Modifying Enzymes Market Segmentation, By Type
Figure 24 Rna-Modifying Enzymes Market Segmentation, By Type
Figure 25 Epigenetics Instruments & Consumables Market, By Type
Figure 26 Next-Generation Sequencers to Command the Largest Share of the Epigenetics Instruments and Consumables Market in 2015
Figure 27 Asia—The Fastest-Growing Regional Market for Epigenetics Instruments and Consumables Between 2015 and 2020
Figure 28 Epigenetics KITS Market Segmentation, By Type
Figure 29 Chip-Seq KITS to Command the Largest Share of the Epigenetics KITS Market in 2015
Figure 30 Asia to Form the Fastest-Growing Regional Market for Epigenetics KITS
Figure 31 Epigenetics Reagents Market Segmentation, By Type
Figure 32 Antibodies to Form the Largest Segment of the Epigenetics Reagents Market in 2020 for Epigenetics
Figure 33 North America Holds the Largest Share for the Epigenetics Reagents Market Between 2015 and 2020
Figure 34 Epigenetics Market Segmentation, By Research Area
Figure 35 Oncology to Form the Largest Research Area Segment in 2015
Figure 36 North America to Command the Largest Share of the Epigenetics Market for Developmental Biology
Figure 37 North America Expected to Dominate the Epigenetics Market for Drug Discovery During the Forecast Period
Figure 38 North America is Expected to Command the Largest Share of the Epigenetics Market for Oncology
Figure 39 North America to Form the Largest Regional Segment of the Other Epigenetics Research Areas Market
Figure 40 Global: Economic Indicators
Figure 41 Epigenetics Market Segmentation, By Region
Figure 42 Asia to Be the Fastest-Growing Region During the Forecast Period for Epigenetics
Figure 43 Epigenetics Market in Asia to Witness the Highest Growth From 2015 to 2020
Figure 44 North America: Economic Indicators for Epigenetics
Figure 45 North America: Market Snapshot for Epigenetics
Figure 46 U.S. Forms the Fastest-Growing Market in North America in 2015
Figure 47 KITS to Command the Largest Share of the Epigenetics Market in North America in 2015
Figure 48 DNA-Modifying Enzymes Segment Dominates the Enzyme Market in North America in 2015
Figure 49 Next-Generation Sequencers Segment Holds Largest Share in the North American Instruments and Consumables Market for Epigenetics in 2015
Figure 50 Oncology to Form the Largest Research Area Segment in North America in 2015
Figure 51 KITS Command the Largest Share of the Epigenetics Market in the U.S. in 2015
Figure 52 DNA-Modifying Enzymes to Command the Largest Share in the Epigenetics Enzyme Market in the U.S. in 2015
Figure 53 Next-Generation Sequencers to Account for the Largest Share in the Epigenetics Instruments and Consumables Market in the U.S. in 2015
Figure 54 Oncology to Form the Largest Research Area Segment in the U.S. in 2015 for Epigenetics
Figure 55 KITS to Command the Largest Share of the Epigenetics Market in Canada in 2015
Figure 56 DNA-Modifying Enzymes to Command the Largest Share in the Epigenetics Enzyme Market in Canada in 2015
Figure 57 Next-Generation Sequencers to Account for the Largest Share in the Canadian Instruments and Consumables Market in 2015
Figure 58 Oncology Forms the Largest Research Areas Segment in Canada in 2015
Figure 59 Europe: Economic Indicators for Epigenetics
Figure 60 KITS to Command the Largest Share of the Market in Europe in 2015
Figure 61 DNA-Modifying Enzymes Segment to Command the Largest Share in the European Enzyme Market in 2015
Figure 62 Next-Generation Sequencers Segment Holds the Largest Share in the European Instruments and Consumables Market (2015)
Figure 63 Oncology to Form the Largest Research Area Segment in Europe in 2015
Figure 64 Asia: Economic Indicators in Epigenetics
Figure 65 Asia: Market Snapshot for Epigenetics
Figure 66 KITS to Command the Largest Share of the Market in Asia in 2015 for Epigenetics
Figure 67 DNA-Modifying Enzymes Segment Dominates the Asian Market in 2015 for Epigenetics
Figure 68 Next-Generation Sequencers to Hold the Largest Market Share in the Asian Instruments and Consumables Market, in 2015
Figure 69 Oncology to Form the Largest Research Area Segment in Asia in 2015
Figure 70 Rest of the World: Economic Indicators for Epigenetics
Figure 71 KITS to Command the Largest Share of the Epigenetics Market in ROW in 2015
Figure 72 DNA-Modifying Enzymes Will Dominate ROW Market in 2015
Figure 73 Next-Generation Sequencers to Form the Largest Instrument and Consumable Segment of the ROW Market
Figure 74 Oncology to Form the Largest Research Area Segment in ROW in 2015 for Epigenetics
Figure 75 New Product Launches is the Key Growth Strategy Adopted By Players in the Epigenetics Market
Figure 76 Financial Performances of the Leading Market Players
Figure 77 Abcam PLC: Company Snapshot
Figure 78 Illumina, Inc.: Company Snapshot
Figure 79 Merck & Co., Inc.: Company Snapshot
Figure 80 Qiagen N.V.: Company Snapshot
Figure 81 Sigma-Aldrich Corporation: Company Snapshot
Figure 82 Thermo Fisher Scientific, Inc.: Company Snapshot

【レポートのキーワード】

エピジェネティクス、修飾酵素、DNAポリメラーゼ、アセチラーゼ、メチルトランスフェラーゼ、エピジェネティクス機器、消耗品、キット、試薬、質量分析計、QPCR、DNA、遺伝子発現

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[エピジェネティクスの世界市場:修飾酵素、DNAポリメラーゼ、アセチラーゼ、メチルトランスフェラーゼ、機器、消耗品、キット、試薬]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。H&I文字はH&Iグローバルリサーチ株式会社の商標(登録第5783645号)です。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。
※当サイトでは2016年06月30日現在 193,802 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆